Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R L Avery

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Archives of Ophthalmology (Chicago, Ill. : 1960)|August 1, 1986
Inhibition of retinal pigment epithelial cell attachment by a synthetic peptide derived from the cell-binding domain of fibronectinR L Avery, B M Glaser
Retina (Philadelphia, Pa.)|January 1, 1995
Pars plana implant and vitrectomy for treatment of neovascular glaucomaJ K Luttrull, R L Avery
Archives of Ophthalmology (Chicago, Ill. : 1960)|October 11, 1990
Systemic amiloride inhibits experimentally induced neovascularizationR L Avery, T B Connor, M Farazdaghi
Retina (Philadelphia, Pa.)|January 1, 1996
Natural history of subfoveal subretinal hemorrhage in age-related macular degenerationR L Avery, S Fekrat, B S Hawkins, et al.
Ophthalmology|January 27, 2000
Initial experience with pneumatically stented baerveldt implant modified for pars plana insertion for complicated glaucomaJ K Luttrull, R L Avery, G Baerveldt, et al.
Cornea|November 1, 1993
Suture abscesses after penetrating keratoplastyA B Leahey, R L Avery, J D Gottsch, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 31, 1995
Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularizationE A Pierce, R L Avery, E D Foley, et al.
Eye (London, England)|September 12, 2015
A novel eye drop application monitor to assess patient compliance with a prescribed regimen: a pilot studyA M Eaton, G M Gordon, A Konowal, et al.
Eye (London, England)|January 31, 2015
Residual edema evaluation with ranibizumab 0.5 mg and 2.0 mg formulations for diabetic macular edema (REEF study)D S Dhoot, D J Pieramici, M Nasir, et al.
The British Journal of Ophthalmology|October 30, 2007
Tractional retinal detachment following intravitreal bevacizumab (Avastin) in patients with severe proliferative diabetic retinopathyJ F Arevalo, M Maia, H W Flynn, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Archives of Ophthalmology (Chicago, Ill. : 1960)|August 1, 1986
Inhibition of retinal pigment epithelial cell attachment by a synthetic peptide derived from the cell-binding domain of fibronectinR L Avery, B M Glaser
Retina (Philadelphia, Pa.)|January 1, 1995
Pars plana implant and vitrectomy for treatment of neovascular glaucomaJ K Luttrull, R L Avery
Archives of Ophthalmology (Chicago, Ill. : 1960)|October 11, 1990
Systemic amiloride inhibits experimentally induced neovascularizationR L Avery, T B Connor, M Farazdaghi
Retina (Philadelphia, Pa.)|January 1, 1996
Natural history of subfoveal subretinal hemorrhage in age-related macular degenerationR L Avery, S Fekrat, B S Hawkins, et al.
Ophthalmology|January 27, 2000
Initial experience with pneumatically stented baerveldt implant modified for pars plana insertion for complicated glaucomaJ K Luttrull, R L Avery, G Baerveldt, et al.
Cornea|November 1, 1993
Suture abscesses after penetrating keratoplastyA B Leahey, R L Avery, J D Gottsch, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 31, 1995
Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularizationE A Pierce, R L Avery, E D Foley, et al.
Eye (London, England)|September 12, 2015
A novel eye drop application monitor to assess patient compliance with a prescribed regimen: a pilot studyA M Eaton, G M Gordon, A Konowal, et al.
Eye (London, England)|January 31, 2015
Residual edema evaluation with ranibizumab 0.5 mg and 2.0 mg formulations for diabetic macular edema (REEF study)D S Dhoot, D J Pieramici, M Nasir, et al.
The British Journal of Ophthalmology|October 30, 2007
Tractional retinal detachment following intravitreal bevacizumab (Avastin) in patients with severe proliferative diabetic retinopathyJ F Arevalo, M Maia, H W Flynn, et al.
Pageof 2